About us
Overview
mAbxience
Our Vision,
Mission, Culture
Business
Growth Story
Leadership
Team
What we do?
Biopharmaceutical
Development
Pipeline
R&D
Quality Philosophy
Manufacturing
& Supply
Commercial Supply
CDMO
mAbxience Sites
Partnerships
Media center
News
Market &
industry news
Videos
CSR
Contact us
Location
Business Development
& Licencies
Join
us
About us
Overview
mAbxience
Our Vision,
Mission, Culture
Business
Growth Story
Leadership
Team
What we do?
Biopharmaceutical
Development
Pipeline
R&D
Quality Philosophy
Manufacturing
& Supply
Commercial Supply
CDMO
mAbxience Sites
Partnerships
Media center
News
Market &
industry news
Videos
CSR
Contact us
Location
Business Development
& Licencies
Join
us
mAbxience |
Glossary
Find here all you need!
VIEW ALL
A - Z
Z - A
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
TRACEABILITY
S
SUBSTITUTION
SINGLE-USE TECHNOLOGY
SIMILARITY
R
Risk management system
Q
QUALITY
P
PHARMACOVIGILANCE
PHARMACOKINETIC TEST
PHARMACODYNAMIC TEST
PERFORMACE QUALIFICATION
Patent
O
OUTSOURCING ACTIVITIES
ORIGINATOR COMPANY
M
MONOCLONAL ANTIBODY (MAB)
MEDIA
MCB (MASTER CELL BANK)
Marketing authorisation
MANUFACTURING SCALE PRODUCTION
Mab
I
INTERCHANGEABILITY
INNOVATIVE REFERENCE DRUG
IMMUNOGENICITY
H
HLA
HIGH-AFFINITY ANTIBODY
HAPTEN
G
GMP
GLYCOSYLATION
GENETIC ENGINEERING
GENE TRANSFER
F
Fucosylation
FORMULATION
FINGERPRINT-LIKE
FEED
FDA
E
EXTRAPOLATION
EMA
C
COMPARABILITY
CLONE
CLINICAL STUDY TRIAL
CHMP
CHIMERIC TRANSGENE
cGMP
CELL LINE
CELL HARVESTING
CELL CULTURE
CELL BANK
CBER
B
BIOTECHNOLOGY
BIOSIMILARITY
BIOSIMILAR
BioSim
BIOPROCESSING
BIOPHARMACEUTICAL
BIOLOGICAL DRUGS
BIOEQUIVALENCE
BIOAVAILABILITY
BIOACTIVITY
BINDING
BATCH CULTURE
BACULOVIRUS
BACTERIOPHAGE
A
AVIDITY
ANTIGENITCITY
ANTIGEN DETERMINANT
ANTIGEN
ANTIBODY
Active ingredient (or active substance)